tiprankstipranks
X4 Pharmaceuticals (XFOR)
NASDAQ:XFOR
US Market
Want to see XFOR full AI Analyst Report?

X4 Pharmaceuticals (XFOR) Blogger Opinions & Sentiment

1,120 Followers

Blogger Sentiment

Bullish: 60.00%
Sector Average
Bullish
XFOR Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
40% SeekingAlpha
20% Zacks
20% Investing
20% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

X4 Pharmaceuticals: Betting On Mavorixafor For Chronic Neutropenia
SeekingAlpha
X4 Pharmaceuticals (XFOR) Maintained at Buy Despite PT Reduction by Stifel | XFOR Stock News
GuruFocus
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of XFOR?
Seeking Alpha’s Avalon Capital Research has a Neutral Sentiment.
    What do Motley Fool contributors think of XFOR?
    Currently there's no blogger sentiment for XFOR.
    What Is XFOR’s Blogger Sentiment?
    XFOR’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for XFOR?
      The most recent blogger prediction for XFOR was made by Avalon Capital Research, who was Neutral on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          CLVLFClinuvel Pharmaceuticals
          ZVRAZevra Therapeutics
          SMMTSummit Therapeutics